GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Hras | multiple interactions | ISO | Hras (Mus musculus) | 6480464 | CTD | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein]; [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK1 protein; [Tunicamycin co-treated with HRAS protein] results in decreased phosphorylation of MAPK3 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of EIF2AK3 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of ERN1 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of HSPA5 protein; [Tunicamycin co-treated with HRAS protein] results in increased expression of PCNA protein; [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein; [Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of AKT1 protein]; HSPA5 protein affects the reaction [[Tunicamycin co-treated with HRAS protein] results in increased phosphorylation of RB1 protein] | PMID:24898257 | |
Go Back to source page | Continue to Ontology report |